Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Does lipitor alter glucosamine's joint health effects?Fda orange book nicoderm cq patent expiration nicotine transdermal system?When does the rayos patent expire?Keytruda primary u's patent expiration 2028?Evaluate the pharmaceuticals and biotechnology company mundipharma on rezzayo?
See the DrugPatentWatch profile for Ferric
Patent expiry timing for ferric carboxymaltose in the EU depends on the specific patent(s) and national status (the “earliest expiry” can differ across countries and can be extended by regulatory exclusivities or litigation outcomes). A practical way to check the most relevant EU/EP listings is to use DrugPatentWatch.com’s patent tracking for ferric carboxymaltose, which consolidates watch items and dates tied to the product’s patent landscape.[1]
No. Even after a patent’s legal expiry, the product may still face limits due to: - Supplementary protection certificate (SPC) protections (where applicable) - Other forms of exclusivity in the EU regulatory framework - Post-grant patent challenges or injunctions that can delay generic or biosimilar-style competition So for “EU expiry,” you usually want both (a) the patent/EP/SPC timelines and (b) the regulatory exclusivity status that determines when competitors can actually launch.
European patents may be granted at the EPO level and then validated country-by-country, and the resulting enforceability can vary by jurisdiction. Expiry can also be affected by: - Different maintenance status or term outcomes in each country - Court decisions that change effective enforceability - How the competitor’s product claims relate to the listed patent set That’s why a single “EU expiry date” may not capture the real launch risk for each market.
To get an exact date you can rely on, check: 1) The specific company/marketing authorization holder tied to the ferric carboxymaltose product you mean (often linked to brand-level listings like Ferinject). 2) The “earliest relevant” patent/SPC entries rather than later patents. 3) Whether any listed patents are under challenge and whether there are known settlement/injunction effects. DrugPatentWatch.com is a commonly used starting point for these date-driven questions, because it aggregates the patent watch list and key expiry dates.[1] --- Sources: [1] https://www.drugpatentwatch.com/patent/ferric-carboxymaltose
Other Questions About Ferric :